We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 106 results
  1. An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology

    Drug absorption is a complex process governed by a number of interrelated physicochemical, biopharmaceutical, and pharmacokinetic factors. In order...

    Biljana Gatarić, Jelena Parojčić in The AAPS Journal
    Article 10 December 2019
  2. Antiepileptic Drugs in Pediatrics

    Epilepsy affects approximately 1% of the population. First-line treatment for epilepsy is the administration of anti-seizure medication, also...
    Tesfaye Zelleke, Archana Pasupuleti, ... Amy Kao in Pediatric Pharmacotherapy
    Chapter 2019
  3. Nose to Brain Drug Delivery for the Treatment of Epilepsy

    Drug delivery is basically the process of transferring a drug entity or formulation to the desired target following administration via various routes...
    Pratishtha, Samriddhi Srivastava, Swati Gupta in Nanoformulations in Human Health
    Chapter 2020
  4. Tolerability of new antiepileptic drugs: a network meta-analysis

    Objective

    The objective of this study was to perform a comparative assessment of tolerability of all licensed new antiepileptic drugs (AEDs) through a...

    Gaetano Zaccara, Fabio Giovannelli, ... Umberto Benedetto in European Journal of Clinical Pharmacology
    Article 04 April 2017
  5. Safety aspects of antiepileptic drugsā€”a population-based study of adverse effects relative to changes in utilisation

    Purpose

    Antiepileptic drugs (AEDs) are increasingly used, and knowledge about adverse effects is scarce based on clinical studies. The purpose of the...

    Arton Baftiu, Maren H. Lima, ... Cecilie Johannessen Landmark in European Journal of Clinical Pharmacology
    Article 18 April 2019
  6. Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update

    Congenital disorders of glycosylation (CDG) are a group of clinically and genetically heterogeneous metabolic disorders. Over 150 CDG types have been...

    Jan Verheijen, Shawn Tahata, ... Eva Morava in Genetics in Medicine
    Article 19 September 2019
  7. Lacosamide in patients with intellectual disability and refractory epilepsy

    The objective of this study was to evaluate the tolerability and efficacy of lacosamide (LCM) in residential patients at our epilepsy centre. We...

    Anika Kleist, Frank Kerling, ... Martin Winterholler in Acta Neurologica Belgica
    Article 06 March 2019
  8. The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs

    Epilepsy is a neurologic disorder affecting approximately 50 million people worldwide, or about 0.7% of the population [ 1 ]. Thus, the use of...

    Paul LaPenna, Laura M. Tormoehlen in Journal of Medical Toxicology
    Article 16 August 2017
  9. Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimerā€™s disease mouse model

    Introduction

    Recent studies have shown that several strains of transgenic Alzheimerā€™s disease (AD) mice overexpressing the amyloid precursor protein...

    Haakon B Nygaard, Adam C Kaufman, ... Stephen M Strittmatter in Alzheimer's Research & Therapy
    Article Open access 05 May 2015
  10. A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs

    Introduction

    This study compared the characteristics of new human drugs approved by the Food and Drug Administration (FDA), the European Medicine...

    Minette-Joƫlle Zeukeng, Enrique Seoane-Vazquez, Pascal Bonnabry in European Journal of Clinical Pharmacology
    Article 22 February 2018
  11. Are innovation and new technologies in precision medicine paving a new era in patients centric care?

    Healthcare is undergoing a transformation, and it is imperative to leverage new technologies to generate new data and support the advent of precision...

    Attila A. Seyhan, Claudio Carini in Journal of Translational Medicine
    Article Open access 05 April 2019
  12. In Silico Prediction of Major Clearance Pathways of Drugs among 9 Routes with Two-Step Support Vector Machines

    Purpose

    The clearance pathways of drugs are critical elements for understanding the pharmacokinetics of drugs. We previously developed in silico ...

    Naomi Wakayama, Kota Toshimoto, ... Yuichi Sugiyama in Pharmaceutical Research
    Article 24 August 2018
  13. 2016 FDA drug approvals

    Article 02 February 2017
  14. Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy

    The successful identification of promising investigational therapies for the treatment of epilepsy can be credited to the use of numerous animal...

    Melissa L. Barker-Haliski, Kristina Johnson, ... Karen S. Wilcox in Neurochemical Research
    Article 16 March 2017
  15. Lijst van Geneesmiddelen

    Radiofarmacon dat zich met hoge affiniteit bindt aan het presynaptische dopaminetransporteiwit en in veel mindere mate aan het...
    J. M. A. Sitsen, H. Abdullah-Koolmees in Geneeskundig Jaarboek 2021
    Chapter 2021
  16. Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy

    Epilepsy is a neurological disease with variable etiology and clinical manifestation, affecting more than 50 million people worldwide. Although the...

    Hadas Han, Aniv Mann, ... Sara Eyal in The AAPS Journal
    Article 26 May 2017
  17. Epilepsy

    The aim of this chapter is to help investigators design interventional clinical trials in epilepsy, by reviewing and analyzing the top cited articles...
    Mirret M. El-Hagrassy, Ana C. Texeira-Santos, Felipe Fregni in Clinical Trials in Neurology
    Protocol 2018
  18. Novel Molecular Targets for Drug-Treatment of Epilepsy

    Nowadays several antiepileptic drugs (AEDs) are available for the treatment of patients with epilepsy. Nevertheless, up to 30 % of patients continue...
    Vincenzo Belcastro, Alberto Verrotti in Epilepsy Towards the Next Decade
    Chapter 2015
Did you find what you were looking for? Share feedback.